Cargando…
Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension
We show that spironolactone use was associated with an increased rate of all-cause hospitalizations, but no difference in hospitalizations for heart failure or pulmonary arterial hypertension, in patients with World Health Organization Group 1 pulmonary arterial hypertension. A possible reason for t...
Autores principales: | Corkish, Morgan E., Devine, Lauren T., Clarke, Megan M., Murray, Brian P., Rose-Jones, Lisa J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709444/ https://www.ncbi.nlm.nih.gov/pubmed/31319761 http://dx.doi.org/10.1177/2045894019868422 |
Ejemplares similares
-
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011) -
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
por: Droste, Annette S, et al.
Publicado: (2009) -
Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
por: Jansen, Pieter M., et al.
Publicado: (2011) -
Aldosterone receptor antagonists: current perspectives and therapies
por: Guichard, Jason L, et al.
Publicado: (2013) -
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
por: Steiner, M Kathryn, et al.
Publicado: (2008)